Geneva Partners’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-503
Closed -$244K 75
2024
Q4
$244K Sell
503
-197
-28% -$103K 0.1% 68
2024
Q3
$354K Sell
700
-1,818
-72% -$976K 0.15% 63
2024
Q2
$1.5M Sell
2,518
-1,275
-34% -$721K 0.62% 42
2024
Q1
$2.17M Buy
3,793
+2,243
+145% +$1.23M 0.96% 34
2023
Q4
$798K Buy
1,550
+608
+65% +$311K 0.44% 48
2023
Q3
$432K Buy
942
+175
+23% +$78.3K 0.29% 53
2023
Q2
$334K Buy
+767
New +$309K 0.22% 62

Other funds holding SNPS

Geneva Partners's SNPS Position: Q1 2025 in Review

Geneva Partners sold out of Synopsys (SNPS) in Q1 2025, closing a stake of 503 shares — an estimated $244K sold.

Geneva Partners first reported a position in SNPS in Q2 2023 and held it in 7 quarters. The position peaked at $2.17M in Q1 2024. 1,282 funds tracked by Wall St. Rank hold SNPS as of Q1 2025.

  • Geneva Partners reported no remaining Synopsys position as of Q1 2025 after selling out during the quarter.
  • Geneva Partners sold 503 Synopsys shares in Q1 2025, an estimated $244K.
  • Geneva Partners first reported a position in Synopsys in Q2 2023 and held it in 7 quarters.
  • Geneva Partners's Synopsys position peaked at $2.17M in Q1 2024.
  • 1,282 funds tracked by Wall St. Rank held Synopsys as of Q1 2025.

Based on Geneva Partners's 13F filing for Q1 2025, filed 30 Apr 2025.